21 Jul 2014 - UT-researcher discovers new method for creating bone tissue and cartilage tissue
UT-Doctoral Degree Candidate Anne Leferink has discovered a new method for creating bone tissue and cartilage tissue. By sequencing structures, it is possible to create a larger piece of bone tissue or cartilage tissue than was possible with current techniques. The aim is to create as much bone as possible using as few stem cells as possible. The technique has to be injectable, so that complex bone defects such as osteoporosis or arthritis can be treated without surgery. Leferink: “I haven't made any bone yet, but we do expect it to work.”
8 Jul 2014 - New drug-eluting stents more effective
Research conducted by University of Twente PhD candidate Kenneth Tandjung has shown that the new generation of drug-eluting stents, which is being used in coronary angioplasty to open narrowed coronary arteries, is safe and more effective than previous generations. He also looked into the use of an additional blood thinner after coronary angioplasty, the influence of diabetes and the results of coronary angioplasty in women. Tandjung is a cardiologist in training at the Thorax Centre of the Medisch Spectrum Twente hospital in Enschede.
7 Jul 2014 - Innovation Grant for Jai Prakash to develop a novel kidney targeting system
Jai Prakash has obtained an Innovation grant of EUR 100,000 from Dutch Kidney Foundation for developing a novel kidney targeting system which could be potentially applied for diagnosis and treatment of chronic kidney diseases. The research project will be conducted in close collaboration with Professor Harry van Goor (University Medical Centre Groningen). Currently there are limited ways to diagnose and almost no ways to treat chronic kidney disease. As proposed in this project, specific cell types in fibrotic kidneys will be targeted using ligand-modified nanoparticles. Success of this project can provide new tools for the development of novel diagnostics and therapeutics for chronic kidney disease.
2 Jul 2014 - 600,000 euros in subsidies for research into lung-on-a-chip
Chip to accelerate research into lung disease treatments and decrease animal testing
1 Jul 2014 - 600,000 euros in subsidies for research into lung-on-a-chip
A research consortium consisting of academics from the University of Twente MIRA research institute, the Leiden University Medical Centre (LUMC) and the Erasmus MC have been granted a 600,000 euro subsidy from the Dutch Lung Foundation. The money will be used to create a three-dimensional lung-on-a-chip. This chip is to improve the development of new methods to treat and regenerate damaged lung tissue and may, in the future, even result in the transplantation of lung tissue that has been grown from the body's own cells.
25 Jun 2014 - More accurate prediction possible on which IC patient benefits from fluid administration
Administering extra fluids to IC patients with a disrupted blood circulation can improve the oxygen supply of tissues and organs. However, in some of the patients it can actually lead to all manner of harmful consequences and, in the worst case scenario, can even lead to the death of the patient. Benno Lansdorp investigated how to better predict which groups of patients will or will not benefit from additional fluids. Amongst other things, he showed that with about fifteen percent of the patients, you can already very accurately predict whether administering additional fluids is desirable or not. He will defend his doctoral thesis at the University of Twente on 27 June.
24 Jun 2014 - Xsens/UT Technology Launched into Outer Space
NASA launched the force and motion measuring shoes, co-developed by Xsens and University of Twente to outer space. One pair of Xsens force-measuring shoes, called ForceShoe, are now onboard the International Space Station (ISS). With the force and motion trackers in each shoe, the intensity of the astronauts’ workouts can be analyzed and perhaps optimized.
19 Jun 2014 - Cooperation for the patient
The third edition of the MIRA event took place in the Grolsch Veste in Enschede today. More than 250 visitors attended this event, with the focus being on cooperation. Cooperation leads to the best science and technology, which ultimately benefits the patient, argued Albert van den Berg, scientific director of the Research Institute for Technical Medicine and Biomedical Engineering, during his opening speech.